Aron D. Mosnaim

1.7k total citations
85 papers, 1.3k citations indexed

About

Aron D. Mosnaim is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Psychiatry and Mental health. According to data from OpenAlex, Aron D. Mosnaim has authored 85 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 23 papers in Cellular and Molecular Neuroscience and 21 papers in Psychiatry and Mental health. Recurrent topics in Aron D. Mosnaim's work include Neuropeptides and Animal Physiology (14 papers), Amino Acid Enzymes and Metabolism (9 papers) and Migraine and Headache Studies (9 papers). Aron D. Mosnaim is often cited by papers focused on Neuropeptides and Animal Physiology (14 papers), Amino Acid Enzymes and Metabolism (9 papers) and Migraine and Headache Studies (9 papers). Aron D. Mosnaim collaborates with scholars based in United States, Chile and United Kingdom. Aron D. Mosnaim's co-authors include Marion E. Wolf, Héctor Sabelli, Javier Puente, Richard L. Borison, Vasant Ranade, Seymour Diamond, Lawrence C. Perlmuter, Joseph J. Ryan, Owen Callaghan and M. Antonieta Valenzuela and has published in prestigious journals such as Nature, American Journal of Psychiatry and Diabetes.

In The Last Decade

Aron D. Mosnaim

83 papers receiving 1.2k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Aron D. Mosnaim 378 351 294 205 202 85 1.3k
S.R. Bareggi 456 1.2× 347 1.0× 440 1.5× 273 1.3× 359 1.8× 87 1.8k
Earl Usdin 511 1.4× 468 1.3× 262 0.9× 142 0.7× 214 1.1× 43 1.5k
Merton Sandler 580 1.5× 752 2.1× 419 1.4× 313 1.5× 198 1.0× 57 2.4k
Robert O. Friedel 343 0.9× 402 1.1× 446 1.5× 185 0.9× 241 1.2× 69 1.4k
H. Dekirmenjian 621 1.6× 336 1.0× 464 1.6× 162 0.8× 338 1.7× 47 1.7k
Godfried M.J. Van Kempen 436 1.2× 310 0.9× 275 0.9× 145 0.7× 141 0.7× 56 1.3k
Richard M. Mangano 813 2.2× 521 1.5× 323 1.1× 182 0.9× 209 1.0× 35 2.4k
Odile Spreux‐Varoquaux 408 1.1× 492 1.4× 274 0.9× 378 1.8× 292 1.4× 55 2.0k
Dorota Żółkowska 626 1.7× 339 1.0× 300 1.0× 73 0.4× 169 0.8× 57 1.3k
Albert N. Nelson 473 1.3× 484 1.4× 255 0.9× 85 0.4× 267 1.3× 24 1.2k

Countries citing papers authored by Aron D. Mosnaim

Since Specialization
Citations

This map shows the geographic impact of Aron D. Mosnaim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aron D. Mosnaim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aron D. Mosnaim more than expected).

Fields of papers citing papers by Aron D. Mosnaim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aron D. Mosnaim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aron D. Mosnaim. The network helps show where Aron D. Mosnaim may publish in the future.

Co-authorship network of co-authors of Aron D. Mosnaim

This figure shows the co-authorship network connecting the top 25 collaborators of Aron D. Mosnaim. A scholar is included among the top collaborators of Aron D. Mosnaim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aron D. Mosnaim. Aron D. Mosnaim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mosnaim, Aron D., Thomas J. Hudzik, & Marion E. Wolf. (2015). Behavioral Effects of β-Phenylethylamine and Various Monomethylated and Monohalogenated Analogs in Mice Are Mediated by Catecholaminergic Mechanisms. American Journal of Therapeutics. 22(6). 412–422. 4 indexed citations
2.
Mosnaim, Aron D., Owen Callaghan, Thomas J. Hudzik, & Marion E. Wolf. (2013). Rat Brain-Uptake Index for Phenylethylamine and Various Monomethylated Derivatives. Neurochemical Research. 38(4). 842–846. 19 indexed citations
3.
Mosnaim, Aron D., et al.. (2013). Changes in Plasma Methionine-Enkephalin Levels Associated With a Cluster Headache Episode. American Journal of Therapeutics. 20(5). 463–468. 2 indexed citations
4.
Mosnaim, Aron D., et al.. (2012). Decreased Plasma Methionine–Enkephalin Levels in Cluster Headache Patients. American Journal of Therapeutics. 19(3). 174–179. 4 indexed citations
5.
6.
Mosnaim, Aron D., et al.. (2008). Degradation Kinetics of Methionine5-Enkephalin by Select Brain Areas From Patients With Chronic Schizophrenia. American Journal of Therapeutics. 15(2). 126–130. 6 indexed citations
7.
Mosnaim, Aron D., Javier Puente, Vasant Ranade, Catherine Hoang, & Marion E. Wolf. (2004). Inhibition of Human Plasma Leucine5-Enkephalin Aminopeptidase Hydrolysis by Various Endogenous Peptides and a Select Number of Clinically Used Drugs. American Journal of Therapeutics. 11(6). 459–465. 9 indexed citations
8.
9.
Blanco, Luz P., Javier Puente, Carolina Carrasco, et al.. (2001). Effect of salmonella-infected human monocytes on natural killer cell cytotoxicity. In vitro studies. International Immunopharmacology. 1(7). 1285–1293. 4 indexed citations
10.
Wolf, Marion E., Vasant Ranade, János Molnár, John C. Somberg, & Aron D. Mosnaim. (2000). Hypercalcemia, Arrhythmia, and Mood Stabilizers. Journal of Clinical Psychopharmacology. 20(2). 260–264. 8 indexed citations
11.
Ranade, Vasant, et al.. (1999). Effect of Angiotensin-Converting Enzyme Therapy on QT Interval Dispersion. American Journal of Therapeutics. 6(5). 257–262. 18 indexed citations
12.
Puente, Javier, et al.. (1997). ENHANCEMENT OF NATURAL KILLER CELL ACTIVITY IN HIV-1-INFECTED SUBJECTS BY A MIXTURE OF THE CALCIUM IONOPHORE A23187 AND THE PHORBOL ESTER TPA. American Journal of Therapeutics. 4(11). 413–422. 4 indexed citations
13.
Wolf, M.E., et al.. (1993). Cutaneous and ocular changes associated with the use of chlorpromazine.. PubMed. 31(8). 365–7. 24 indexed citations
14.
Mosnaim, Aron D., Owen Callaghan, & Marion E. Wolf. (1989). Hydroxylation of phenylethylamine by rat liver preparations. Inhibition studies. General Pharmacology The Vascular System. 20(4). 463–467. 3 indexed citations
15.
Mosnaim, Aron D., et al.. (1988). Studies of the in vitro human plasma degradation of methionine-enkephalin. General Pharmacology The Vascular System. 19(5). 729–733. 21 indexed citations
16.
Wolf, Marion E., et al.. (1988). Posttraumatic stress disorder in vietnam veterans clinical and EEG findings; possible therapeutic effects of carbamazepine. Biological Psychiatry. 23(6). 642–644. 72 indexed citations
17.
Wolf, Marion E., et al.. (1983). Phenylethylamine-Like Properties of Baclofen. Neuropsychobiology. 9(4). 219–222. 5 indexed citations
18.
Mosnaim, Aron D. & Marion E. Wolf. (1978). Phenylethylamine : biological mechanisms and clinical aspects. M. Dekker eBooks. 8 indexed citations
19.
Zeller, E. A., et al.. (1976). Phenylethylamine: studies on the mechanism of its physiological action.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 15. 75–86. 7 indexed citations
20.
Sabelli, Héctor, et al.. (1976). Biochemical plasticity of synaptic transmission: a critical review of Dale's Principle.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 11(4). 481–524. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by S.R. Bareggi Breakdown of academic impact, for papers by Earl Usdin Breakdown of academic impact, for papers by Merton Sandler Breakdown of academic impact, for papers by Robert O. Friedel Breakdown of academic impact, for papers by H. Dekirmenjian Breakdown of academic impact, for papers by Godfried M.J. Van Kempen Breakdown of academic impact, for papers by Richard M. Mangano Breakdown of academic impact, for papers by Odile Spreux‐Varoquaux Breakdown of academic impact, for papers by Dorota Żółkowska Breakdown of academic impact, for papers by Albert N. Nelson
Rankless by CCL
2026